Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Screening mammography: benefit of double reading by breast density

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Mortality after contralateral breast cancer in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Pre-diagnostic changes in body mass index and mortality among breast cancer patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Rational targeting of population groups and residential areas for colorectal cancer screening

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Publishing your trial protocols with Acta Oncologica; your contribution to scientific transparency

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Function, information, and contributions: An evaluation of national multidisciplinary team meetings for rare cancers

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Whether or not breast cancer can be a feature of the hereditary nonpolyposis colorectal cancer (HNPCC) syndrome has been debated. In order to clarify if defective mismatch repair (MMR) may indeed play a role in breast cancer, we used the Danish HNPCC register to identify all breast cancers that occurred in MMR gene mutation carriers. In total, 20 female mutation carriers were diagnosed with breast cancer at mean 50 years of age. These tumors were predominantly ductal carcinomas with extensive lymphocytic reactions in 8/14 evaluated tumors. MMR protein immunostaining showed loss of expression of MLH1, MSH2 or MSH6 corresponding to the mutations identified in 7 of the 16 cases investigated, and these tumors were diagnosed at mean 50 (33-66) years of age. The demonstration of defective MMR in a substantial proportion of the breast cancers studied links yet another tumor type to HNPCC. Though the low number do not motivate surveillance, our observation supports a role for defective MMR in breast cancer progression in HNPCC, presumably through accelerated accumulation of mutations in breast cancer-associated genes.
Original languageEnglish
JournalBreast Cancer Research and Treatment
Volume120
Issue number3
Pages (from-to)777-82
Number of pages5
DOIs
Publication statusPublished - 2010

    Research areas

  • Adaptor Proteins, Signal Transducing, Adult, Aged, Breast Neoplasms, Carcinoma, Ductal, Breast, Colorectal Neoplasms, Hereditary Nonpolyposis, DNA Mismatch Repair, DNA-Binding Proteins, Denmark, Endometrial Neoplasms, Female, Humans, Male, Middle Aged, MutS Homolog 2 Protein, Neoplasms, Multiple Primary, Nuclear Proteins, Ovarian Neoplasms, Pedigree, Urethral Neoplasms

ID: 32551293